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Abstract 
Association between multiple sclerosis (MS) and parkinsonism is rarely reported. We 
describe clinical, radiological and DAT scan findings in two patients presenting with 
parkinsonism. MRI revealed demyelinating lesions of the central nervous system 
consistent with MS in both patients. On the other hand, DAT scan findings were 
supportive of Parkinson's disease. There is still an open debate whether MS lesions 
can cause parkinsonism, or these are just coincidental findings of two different 
diseases in the same patient. Although there are cases of causal relationship between 
parkinsonism and MS, some literature reports and our observations suggest that 
Parkinson’s disease and MS can coexist as two separate diseases in the same patient. 
It is possible that the symptoms of Parkinson’s disease can be aggravated by MS 
plaques, explaining the favorable response to corticosteroids in some patients.    
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Introduction 
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central 
nervous system (CNS). MS plaques are characteristically found in the periventricular 
white matter supratentorially and the most common infratentorial locations are the 
surface of the pons, the cerebellar peduncles, and white matter regions adjacent to the 
fourth ventricle. As subcortical gray matter also contains myelinated fibers, 
demyelinating lesions can be found in the striatum, pallidum, thalamus, brainstem and 
cerebral cortex as well1. Although demyelination in the basal ganglia is a hallmark of 
acute disseminated encephalomyelitis (ADEM)2, symptoms due to deep gray matter 
damage can infrequently occur in MS patients. The most frequent movement 
disorders associated with multiple sclerosis are paroxysmal dystonias (tonic spasms), 
ballism/chorea, and palatal myoclonus, while parkinsonism associated with CNS 
demyelination appears to be a very rare finding3. There is still an open debate whether 
MS lesions can cause parkinsonian symptoms, or the reported cases are just 
coincidental findings of two different diseases in the same patient. We report on two 
patients with parkinsonism and demyelinating lesions of the CNS. 
 
Case Reports 
Case 1. In 2000, a 38-year-old patient with a history of meningitis at age 21 and two 
spontaneous abortions developed tremor in the left hand. Neurologic examination at 
that time revealed resting tremor and rigor with cogwheel phenomenon in the left 
hand. Because of her young age, MRI was performed and revealed multiple white 
matter hyperintensities without brainstem lesions. Spinal cord MRI revealed one 
lesion at C4 level (Fig. 1). Cerebrospinal fluid (CSF) findings, serum and CSF 
Borrelia burgdorferi, immunologic tests (ANF, anticardiolipin antibodies, ANCA) 
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and visual evoked potentials (VEP) were normal, and she was treated with 
intravenous corticosteroids with good recovery of the symptoms. Two years later 
(January 2002), during pregnancy, she developed resting tremor in her left arm and 
leg again. Neurologic examination revealed resting tremor in the left extremities with 
rigor, cogwheel phenomenon and reduced arm flexion. She had bradykinesia. Upon 
delivery, she experienced worsening of her symptoms. This time, along with 
corticosteroid treatment, therapy with levodopa was introduced, resulting in good 
recovery and almost complete reversal of neurological deficit. In 2006, exacerbation 
of her disease recurred; this time she developed diplopia along with extrapyramidal 
symptoms and characteristic parkinsonian gate. Repeat MRI, T2 and FLAIR 
sequences revealed a greater number of demyelinating lesions, however, without 
enhancement on gadolinium application. T1 sequence revealed one black hole. DAT 
scan was performed to show a low level of dopamine carrying protein in the right 
striatum, with normal findings on the left side (Fig. 3). These findings were consistent 
with unilateral Parkinson's disease (PD). The diagnosis was relapsing remitting 
multiple sclerosis and PD. 
Case 2. In August 2000, a 53-year-old woman developed resting tremor and 
clumsiness in the right arm and leg. One year later, because of persistence of her 
symptoms, brain MRI was performed and revealed multiple supratentorial white 
matter hyperintensities (Fig. 1). CSF examination was negative for oligoclonal bands 
and corticosteroid therapy led to significant improvement of her symptoms. 
Immunologic tests were negative and VEP were normal. In the next couple of years 
she had 4 new bouts of the symptoms, each time with good response to corticosteroid 
therapy. On control MRI in 2003, multiple white matter hyperintensities, were 
observed, mostly in both semioval centers and on the border of white and gray matter 
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(Fig. 2). Spinal cord MRI was normal. Her symptoms gradually progressed and she 
developed rigor of the left extremities. In April 2007 she started to develop forceful 
closure of the eyelids, neurological examination revealed blepharospasm along with 
marked rigor of all four extremities and resting tremor of the right hand. She had no 
eye movement abnormalities, no autonomic dysfunction, and postural reflexes were 
preserved. She also had signs of pyramidal lesion, with brisk reflexes of the right 
extremities and positive Babinski sign. Repeat brain MRI revealed new demyelinating 
lesions, without post contrast enhancement, and no brain stem or spinal cord lesions. 
DAT scan was performed to reveal very low levels of dopamine carrying protein in 
the caudate nucleus and putamen on the left side, and a low level of DAT in the left 
putamen with normal levels in the left caudate nucleus (Fig. 3). Levodopa therapy 
was started, with excellent recovery. The diagnosis of relapsing remitting multiple 
sclerosis and PD was confirmed.  
 
Discussion 
Nelson and Paulson proposed an interesting hypothesis that idiopathic PD may follow 
subclinical episodes of perivenous demyelination4. They suggest that the 
etiopathology of Lewy bodies (a hallmark of PD) may involve repeated perivenous 
demyelination of pigmented neurons that results in central chromatolysis, and that 
subclinical demyelinoclastic processes in time and space may result in PD. These 
perivenous demyelinations are a hallmark of ADEM, and there are many reported 
cases of postinfectious and postvaccinal parkinsonism (ADEM variants) that 
excellently responded to levodopa therapy3.  
There are several case reports describing patients with parkinsonism and 
demyelinating lesions of MS3,5-11. There are two main hypotheses that try to explain 
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this association. The first one is that it is purely accidental3,5,6. The best documented 
case of coincidental MS and PD in the same patient is that reported by Valkovic et 
al.6. The authors base their conclusion on negative response of parkinsonian 
symptoms to immunosuppressive therapy or steroids, and findings of neuroimaging 
studies (MRI with absent lesions in the basal ganglia and a characteristic finding on 
DAT scan). 
The other hypothesis is that demyelinating lesions can affect dopaminergic pathways, 
and thus cause parkinsonian features. It is supported by several case reports which 
bring into correlation demyelinating lesions and affection of dopaminergic system. 
Localization of the lesions can be in the nigrostriatal pathway7, globus pallidus8, or 
nucleus ruber9. Another supportive evidence of causal relationship is marked 
improvement of parkinsonism on corticosteroid therapy10. Some authors, on the other 
hand, describe patients with MS and PD, in which critically positioned MS plaques 
aggravate PD symptoms11.   
There are also cases of coexistent MS with other neurodegenerative diseases 
associated with parkinsonism. The most important one is pathologically proven 
coexistence of MS with multiple system atrophy (MSA), in which parkinsonian 
symptoms were due to MSA12. There also are reports on MS in patients with 
spinocerebellar ataxia (SCA)13, and some studies have shown that allelic variants of 
the SCA 2 gene influence susceptibility to MS14. 
Blepharospasm is an extremely rare symptom in MS15. Patients with blepharospasm 
and MS usually have brainstem lesions. It is interesting that our patient with 
blepharospasm had no brainstem lesions. However, it is known that MS symptoms do 
not always correlate well with demyelinating plaque location, as shown in patients 
with MS and cranial nerve palsies (Zadro et al., this issue of CNN)16. On the other 
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hand, blepharospasm is also a very rare symptom of PD17, and only a minority of 
patients with idiopathic blepharospasm develop PD18. Patients with progressive 
supranuclear palsy (PSP) are more prone to develop blepharospasm in the course of 
the illness; however, our patient had no cognitive decline or vertical eye movement 
paresis, so the diagnosis of PSP was unlikely.  
The diagnosis of relapsing remitting MS in both of our patients fulfilled the revised 
McDonald criteria19. On the other hand, DAT scan findings in both patients were 
consistent with PD, and both patients responded to levodopa therapy.  
In conclusion, although there are cases of causal relationship between parkinsonism 
and MS, some of the reported cases and our two patients support the concept that PD 
and MS can coexist as two separate diseases in the same patient. It is possible that PD 
symptoms may be aggravated by MS plaques, explaining the good response to 
corticosteroids in some of the reported patients.    
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Figures 
 
Figure 1. Patient 1 MRIs: (a) brain MRI, T2 sequence; (b) brain MRI, T1 sequence; 
(c) spinal cord MRI; showing multiple supratentorial and cervical spinal cord lesions.  
 
 
Figure 2. Patient 2 brain MRI: (a) T2 sequence; (b) T1 sequence; showing multiple 
demyelinating lesions.  
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Figure 3. DAT scan findings: (a) patient 1 – note the low level of dopamine carrying 
protein in the right striatum; (b) patient 2 – note very low levels of DAT in the 
caudate nucleus and putamen on the left side, and a low level of DAT in the left 
putamen.  
 
 
 
 
 
 
